Work

PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study

Year: 2022

Type: article

Study design: Clinical Trial

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(22)00097-3

Authors: Julie Delyon, Lucie Biard, Marion Renaud, Matthieu Resche-Rigon, Jérôme Le Goff, Stéphane Dalle, Valentine Heidelberger, Laetitia Da Meda, Laurie Toullec, Guislaine Carcelain, Samia Mourah, Sophie Caillat-Zucman, Vincent Allain, Maxime Battistella, Céleste Lebbe

Institutions: Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, HIPI - Immunologie humaine, physiopathologie et immunithérapie, Equipe de Recherche en Epidémiologie Nutritionnelle, Centre de Recherche Épidémiologie et Statistique, Department of Virology, Lyon 1 Université, Hôpital Lyon Sud, Centre de Recherche en Cancérologie de Lyon, Hôpital Avicenne, Hôpital Robert-Debré

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Meso Scale Diagnostics, MSD France

OpenAlex ID: W4220778659

FWCI: 6.567

Cites: 41

Cited by: 76

Related to: 10